DK0464638T3 - Oligonukleotidanaloge med terminale 3-3- eller 5-5-internukleotidbindinger. - Google Patents

Oligonukleotidanaloge med terminale 3-3- eller 5-5-internukleotidbindinger.

Info

Publication number
DK0464638T3
DK0464638T3 DK91110570.8T DK91110570T DK0464638T3 DK 0464638 T3 DK0464638 T3 DK 0464638T3 DK 91110570 T DK91110570 T DK 91110570T DK 0464638 T3 DK0464638 T3 DK 0464638T3
Authority
DK
Denmark
Prior art keywords
terminal
oligonucleotide analogs
internucleotide bonds
internucleotide
bonds
Prior art date
Application number
DK91110570.8T
Other languages
Danish (da)
English (en)
Inventor
Hannelore Roesch
Anja Froehlich
Jose Flavio Ramalho-Ortigao
Matthias Prof Dr Montenarh
Hartmut Prof Dr Seliger
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of DK0464638T3 publication Critical patent/DK0464638T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R15/00—Details of measuring arrangements of the types provided for in groups G01R17/00 - G01R29/00, G01R33/00 - G01R33/26 or G01R35/00
    • G01R15/14—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks
    • G01R15/18—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers
    • G01R15/186—Adaptations providing voltage or current isolation, e.g. for high-voltage or high-current networks using inductive devices, e.g. transformers using current transformers with a core consisting of two or more parts, e.g. clamp-on type

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Power Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
DK91110570.8T 1990-07-02 1991-06-26 Oligonukleotidanaloge med terminale 3-3- eller 5-5-internukleotidbindinger. DK0464638T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4021019 1990-07-02

Publications (1)

Publication Number Publication Date
DK0464638T3 true DK0464638T3 (da) 1997-10-13

Family

ID=6409497

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91110570.8T DK0464638T3 (da) 1990-07-02 1991-06-26 Oligonukleotidanaloge med terminale 3-3- eller 5-5-internukleotidbindinger.

Country Status (22)

Country Link
US (1) US5750669A (hu)
EP (1) EP0464638B1 (hu)
JP (1) JP3186795B2 (hu)
KR (1) KR100200400B1 (hu)
AT (1) ATE151076T1 (hu)
AU (1) AU647143B2 (hu)
CA (1) CA2045891C (hu)
CZ (1) CZ285408B6 (hu)
DE (1) DE59108644D1 (hu)
DK (1) DK0464638T3 (hu)
ES (1) ES2099718T3 (hu)
FI (1) FI104177B1 (hu)
GR (1) GR3023432T3 (hu)
HU (1) HU215147B (hu)
IE (1) IE912309A1 (hu)
IL (1) IL98672A (hu)
NO (1) NO303018B1 (hu)
NZ (1) NZ238769A (hu)
PT (1) PT98169B (hu)
SK (1) SK279544B6 (hu)
TW (1) TW206232B (hu)
ZA (1) ZA915056B (hu)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223618A (en) * 1990-08-13 1993-06-29 Isis Pharmaceuticals, Inc. 4'-desmethyl nucleoside analog compounds
DK0593901T3 (da) * 1992-09-24 1997-10-27 Hoechst Ag Oligoribonucleotid- og ribozym-analoge med terminale 3-3- og 5-5-bindinger.
HU9501974D0 (en) * 1993-03-31 1995-09-28 Sterling Winthrop Inc Oligonucleotides with amide linkages replacing phosphodiester linkages
US6015886A (en) * 1993-05-24 2000-01-18 Chemgenes Corporation Oligonucleotide phosphate esters
US6605708B1 (en) * 1993-07-28 2003-08-12 Hybridon, Inc. Building blocks with carbamate internucleoside linkages and oligonucleotides derived therefrom
US5855911A (en) * 1995-08-29 1999-01-05 Board Of Regents, The University Of Texas System Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
US9096636B2 (en) * 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US7309692B1 (en) * 1996-07-08 2007-12-18 Board Of Regents, The University Of Texas System Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en) * 1996-10-04 2005-12-20 Board Of Regents, The University Of Texas Systems Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
CN1060177C (zh) * 1997-06-28 2001-01-03 中国科学院上海生物化学研究所 3′－单磷酸化寡核苷酸
US7704962B1 (en) 1997-10-03 2010-04-27 Board Of Regents, The University Of Texas System Small oligonucleotides with anti-tumor activity
US7285288B1 (en) 1997-10-03 2007-10-23 Board Of Regents, The University Of Texas System Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US6087112A (en) * 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US20030180789A1 (en) * 1998-12-30 2003-09-25 Dale Roderic M.K. Arrays with modified oligonucleotide and polynucleotide compositions
DE19935756A1 (de) * 1999-07-27 2001-02-08 Mologen Forschungs Entwicklung Kovalent geschlossenes Nukleinsäuremolekül zur Immunstimulation
DE19935303A1 (de) 1999-07-28 2001-02-08 Aventis Pharma Gmbh Oligonukleotide zur Inhibierung der Expression von humanem eg5
US6271360B1 (en) 1999-08-27 2001-08-07 Valigen (Us), Inc. Single-stranded oligodeoxynucleotide mutational vectors
EP1702983A3 (en) 2000-04-13 2007-01-10 Medical University of South Carolina Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
JP2004503560A (ja) * 2000-06-13 2004-02-05 プロリゴ・エルエルシー 固相オリゴ合成の普遍固形支持体とその製造及び使用の方法
ES2298269T3 (es) * 2000-09-26 2008-05-16 Idera Pharmaceuticals, Inc. Modulacion de la actividad inmunoestimulante de analogos oligonucleotidicos inmunoestimulantes mediante cambios quimicos posicionales.
GB0114007D0 (en) * 2001-06-08 2001-08-01 Isis Innovation Oilgonucleotides
US7070933B2 (en) * 2001-09-28 2006-07-04 Gen-Probe Incorporated Inversion probes
WO2003061386A1 (en) * 2002-01-03 2003-07-31 Board Of Regents, The University Of Texas System Wt1 antisense oligos for the inhibition of breast cancer
EP1474432A1 (en) * 2002-02-04 2004-11-10 Biomira Inc. Immunostimulatory, covalently lipidated oligonucleotides
EP1560839A4 (en) 2002-11-05 2008-04-23 Isis Pharmaceuticals Inc CHIMERIC OLIGOMER COMPOUNDS AND THEIR USE IN GENE MODULATION
WO2004044136A2 (en) 2002-11-05 2004-05-27 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
EP1765415A4 (en) * 2004-06-03 2010-03-24 Isis Pharmaceuticals Inc OLIGOMERIC COMPOUNDS FACILITATING THE "RISC" LOAD
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
CA2679750A1 (en) 2008-09-23 2010-03-23 Nexus Dx, Inc. Methods for detecting nucleic acids in a sample
EP2781523A1 (en) 2013-03-18 2014-09-24 Miltenyi Biotec GmbH Lipophilic oligonucleotide analogs
KR101323476B1 (ko) * 2013-06-12 2013-10-31 조선미 건물용 층간소음 방지재와 이를 이용한 층간소음 방지구조 및 그 시공 방법
LU92821B1 (en) 2015-09-09 2017-03-20 Mologen Ag Combination comprising immunostimulatory oligonucleotides
GB2542425A (en) 2015-09-21 2017-03-22 Mologen Ag Means for the treatment of HIV
KR102475301B1 (ko) * 2016-04-08 2022-12-09 트랜슬레이트 바이오 인코포레이티드 다량체 코딩 핵산 및 그 용도
WO2018223056A1 (en) 2017-06-02 2018-12-06 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof
CA3096667A1 (en) * 2018-04-12 2019-10-17 Wave Life Sciences Ltd. Oligonucleotide compositions and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123610A (en) * 1977-03-09 1978-10-31 The United States Government Nucleic acid crosslinking agent and affinity inactivation of nucleic acids therewith
US4711955A (en) * 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
FR2540122B1 (fr) * 1983-01-27 1985-11-29 Centre Nat Rech Scient Nouveaux composes comportant une sequence d'oligonucleotide liee a un agent d'intercalation, leur procede de synthese et leur application
DE3332068A1 (de) * 1983-09-06 1985-03-21 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von nukleosidalkyl-, aralkyl- und arylphosphoniten und -phosphonaten
US4795700A (en) * 1985-01-25 1989-01-03 California Institute Of Technology Nucleic acid probes and methods of using same
US5276019A (en) * 1987-03-25 1994-01-04 The United States Of America As Represented By The Department Of Health And Human Services Inhibitors for replication of retroviruses and for the expression of oncogene products
EP0406309A4 (en) * 1988-03-25 1992-08-19 The University Of Virginia Alumni Patents Foundation Oligonucleotide n-alkylphosphoramidates
WO1990012022A1 (en) * 1989-03-31 1990-10-18 University Patents, Inc. Polynucleotide phosphorodithioates as therapeutic agents for retroviral infections

Also Published As

Publication number Publication date
EP0464638A2 (de) 1992-01-08
EP0464638B1 (de) 1997-04-02
HU912215D0 (en) 1991-12-30
NZ238769A (en) 1993-11-25
NO303018B1 (no) 1998-05-18
IL98672A0 (en) 1992-07-15
DE59108644D1 (de) 1997-05-07
ATE151076T1 (de) 1997-04-15
JP3186795B2 (ja) 2001-07-11
IE912309A1 (en) 1992-01-15
KR100200400B1 (ko) 1999-06-15
PT98169A (pt) 1993-09-30
AU7947591A (en) 1992-01-02
CZ285408B6 (cs) 1999-08-11
US5750669A (en) 1998-05-12
ZA915056B (en) 1992-03-25
NO912585D0 (no) 1991-07-01
GR3023432T3 (en) 1997-08-29
JPH05222088A (ja) 1993-08-31
FI913169A (fi) 1992-01-03
HU215147B (hu) 2000-03-28
KR920002625A (ko) 1992-02-28
TW206232B (hu) 1993-05-21
ES2099718T3 (es) 1997-06-01
NO912585L (no) 1992-01-03
EP0464638A3 (en) 1992-09-02
CA2045891C (en) 2003-07-22
FI104177B (fi) 1999-11-30
FI104177B1 (fi) 1999-11-30
IL98672A (en) 1995-12-08
FI913169A0 (fi) 1991-06-28
SK279544B6 (sk) 1998-12-02
PT98169B (pt) 1998-12-31
HUT62010A (en) 1993-03-29
CA2045891A1 (en) 1992-01-03
CS201491A3 (en) 1992-01-15
AU647143B2 (en) 1994-03-17

Similar Documents

Publication Publication Date Title
DK0464638T3 (da) Oligonukleotidanaloge med terminale 3-3- eller 5-5-internukleotidbindinger.
DE3884453D1 (de) Homogene additionscopolymere von ethylen und cycloolefinmonomeren und deren herstellung.
MA22905A1 (fr) Nouvelles sequences d'adn .
GR1000118B (el) Συνθεσις 1,2-διοξετανων & ενδιαμεσαι ουσιαι δι αυτην.
PT88275A (pt) Processo para a preparacao de composicoes farmaceuticas contendo 5-amino ou amino substituido-1,2,3-triazois uteis como agentes antiproliferativos
EP0354185A3 (en) Piperidine-triazine compounds for use as stabilizers for organic materials
DE3673203D1 (de) Silylgruppen enthaltende vinylharze und haertungszusammensetzung.
DK656488A (da) Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser
ES2080736T3 (es) Uso de 2,3,4,5-tetrahidro-1h-3-benzazepinas en el tratamiento de trastornos neurologicos.
FR2645157B1 (fr) Inhibition selective de l'adn polymerase
ES2102772T3 (es) Compuesto citotoxico y antiviral.
FR2674253B1 (fr) Composition lyophilisee pour la multiplication de sequences d'acides nucleiques.
DE3871272D1 (de) Oberflaechenbehandlung von polyolefinformkoerpern.
ES2066897T3 (es) 5,11-dihidro-6h-pirido(2,3-b)(1,4)benzodiazepin-6-onas y -tionas y su uso en la prevencion o el tratamiento del sida.
EP0428107A3 (en) Treatment of multi-drug resistant tumors with quinolyl- and isoquinolyloxazole-2-ones
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
Gharavi Molecular cloning of the human lipoxygenase gene
IT8619957A0 (it) Composizione profumata per il trattamento di articoli in pelle e cuoio.
ES536881A0 (es) Mejoras introducidas en el objeto de la patente de invencion n. 516325.
IT8821384A0 (it) 5 pirimidincarbossamidi sostituite e composizioni farmaceutiche contenenti le stesse per il trattamento di leucemia.
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis
TH17364A (hu)
ES555466A0 (es) Mejoras introducidas en el objeto de la patente de invencion 516.212 por perfeccionamientos introducidos en atomizadores agricolas
IT214763Z2 (it) Struttura per l'aerazione di scantinati.
IT8603380A1 (it) Ventilatore perfezionato per l'areazione di ambienti chiusi